back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-12-15 15:10 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$884,320
+88,432 vol $10.00 each |
147,198 | |
| Filed 2021-12-10 14:46 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$387,660
+38,766 vol $10.00 each |
58,766 | |
| Filed 2021-12-10 14:45 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$846,462
+56,020 vol $15.11 each |
169,087 | |
| Filed 2020-11-13 14:50 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$200,000
+20,000 vol $10.00 each |
20,000 | |
| Filed 2020-11-13 14:49 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 12:40 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$389,000
+25,000 vol $15.56 each |
113,067 | |
| Filed 2019-06-11 10:53 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$434,140
+27,919 vol $15.55 each |
88,067 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$225,405
+27,027 vol $8.34 each |
60,148 | |
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
33,121 |